Copyright Reports & Markets. All rights reserved.

Global Sexually Transmitted Diseases Testing Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Sexually Transmitted Diseases Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Chlamydia Testing
    • 1.2.3 Gonorrhea Testing
    • 1.2.4 Syphilis Testing
    • 1.2.5 HIV Testing
    • 1.2.6 HSV Testing
    • 1.2.7 HPV Testing
    • 1.2.8 Chancroid Testing
    • 1.2.9 Other
  • 1.3 Market by Application
    • 1.3.1 Global Sexually Transmitted Diseases Testing Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Clinics
    • 1.3.3 Hospitals
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Sexually Transmitted Diseases Testing Market Perspective (2016-2027)
  • 2.2 Sexually Transmitted Diseases Testing Growth Trends by Regions
    • 2.2.1 Sexually Transmitted Diseases Testing Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Sexually Transmitted Diseases Testing Historic Market Share by Regions (2016-2021)
    • 2.2.3 Sexually Transmitted Diseases Testing Forecasted Market Size by Regions (2022-2027)
  • 2.3 Sexually Transmitted Diseases Testing Industry Dynamic
    • 2.3.1 Sexually Transmitted Diseases Testing Market Trends
    • 2.3.2 Sexually Transmitted Diseases Testing Market Drivers
    • 2.3.3 Sexually Transmitted Diseases Testing Market Challenges
    • 2.3.4 Sexually Transmitted Diseases Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Sexually Transmitted Diseases Testing Players by Revenue
    • 3.1.1 Global Top Sexually Transmitted Diseases Testing Players by Revenue (2016-2021)
    • 3.1.2 Global Sexually Transmitted Diseases Testing Revenue Market Share by Players (2016-2021)
  • 3.2 Global Sexually Transmitted Diseases Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Sexually Transmitted Diseases Testing Revenue
  • 3.4 Global Sexually Transmitted Diseases Testing Market Concentration Ratio
    • 3.4.1 Global Sexually Transmitted Diseases Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases Testing Revenue in 2020
  • 3.5 Sexually Transmitted Diseases Testing Key Players Head office and Area Served
  • 3.6 Key Players Sexually Transmitted Diseases Testing Product Solution and Service
  • 3.7 Date of Enter into Sexually Transmitted Diseases Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Sexually Transmitted Diseases Testing Breakdown Data by Type

  • 4.1 Global Sexually Transmitted Diseases Testing Historic Market Size by Type (2016-2021)
  • 4.2 Global Sexually Transmitted Diseases Testing Forecasted Market Size by Type (2022-2027)

5 Sexually Transmitted Diseases Testing Breakdown Data by Application

  • 5.1 Global Sexually Transmitted Diseases Testing Historic Market Size by Application (2016-2021)
  • 5.2 Global Sexually Transmitted Diseases Testing Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Sexually Transmitted Diseases Testing Market Size (2016-2027)
  • 6.2 North America Sexually Transmitted Diseases Testing Market Size by Type
    • 6.2.1 North America Sexually Transmitted Diseases Testing Market Size by Type (2016-2021)
    • 6.2.2 North America Sexually Transmitted Diseases Testing Market Size by Type (2022-2027)
    • 6.2.3 North America Sexually Transmitted Diseases Testing Market Size by Type (2016-2027)
  • 6.3 North America Sexually Transmitted Diseases Testing Market Size by Application
    • 6.3.1 North America Sexually Transmitted Diseases Testing Market Size by Application (2016-2021)
    • 6.3.2 North America Sexually Transmitted Diseases Testing Market Size by Application (2022-2027)
    • 6.3.3 North America Sexually Transmitted Diseases Testing Market Size by Application (2016-2027)
  • 6.4 North America Sexually Transmitted Diseases Testing Market Size by Country
    • 6.4.1 North America Sexually Transmitted Diseases Testing Market Size by Country (2016-2021)
    • 6.4.2 North America Sexually Transmitted Diseases Testing Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Sexually Transmitted Diseases Testing Market Size (2016-2027)
  • 7.2 Europe Sexually Transmitted Diseases Testing Market Size by Type
    • 7.2.1 Europe Sexually Transmitted Diseases Testing Market Size by Type (2016-2021)
    • 7.2.2 Europe Sexually Transmitted Diseases Testing Market Size by Type (2022-2027)
    • 7.2.3 Europe Sexually Transmitted Diseases Testing Market Size by Type (2016-2027)
  • 7.3 Europe Sexually Transmitted Diseases Testing Market Size by Application
    • 7.3.1 Europe Sexually Transmitted Diseases Testing Market Size by Application (2016-2021)
    • 7.3.2 Europe Sexually Transmitted Diseases Testing Market Size by Application (2022-2027)
    • 7.3.3 Europe Sexually Transmitted Diseases Testing Market Size by Application (2016-2027)
  • 7.4 Europe Sexually Transmitted Diseases Testing Market Size by Country
    • 7.4.1 Europe Sexually Transmitted Diseases Testing Market Size by Country (2016-2021)
    • 7.4.2 Europe Sexually Transmitted Diseases Testing Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Sexually Transmitted Diseases Testing Market Size (2016-2027)
  • 8.2 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Type
    • 8.2.1 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Application
    • 8.3.1 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Region
    • 8.4.1 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Sexually Transmitted Diseases Testing Market Size (2016-2027)
  • 9.2 Latin America Sexually Transmitted Diseases Testing Market Size by Type
    • 9.2.1 Latin America Sexually Transmitted Diseases Testing Market Size by Type (2016-2021)
    • 9.2.2 Latin America Sexually Transmitted Diseases Testing Market Size by Type (2022-2027)
    • 9.2.3 Latin America Sexually Transmitted Diseases Testing Market Size by Type (2016-2027)
  • 9.3 Latin America Sexually Transmitted Diseases Testing Market Size by Application
    • 9.3.1 Latin America Sexually Transmitted Diseases Testing Market Size by Application (2016-2021)
    • 9.3.2 Latin America Sexually Transmitted Diseases Testing Market Size by Application (2022-2027)
    • 9.3.3 Latin America Sexually Transmitted Diseases Testing Market Size by Application (2016-2027)
  • 9.4 Latin America Sexually Transmitted Diseases Testing Market Size by Country
    • 9.4.1 Latin America Sexually Transmitted Diseases Testing Market Size by Country (2016-2021)
    • 9.4.2 Latin America Sexually Transmitted Diseases Testing Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Sexually Transmitted Diseases Testing Market Size (2016-2027)
  • 10.2 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Type
    • 10.2.1 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Application
    • 10.3.1 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Country
    • 10.4.1 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 BioMerieux
    • 11.1.1 BioMerieux Company Details
    • 11.1.2 BioMerieux Business Overview
    • 11.1.3 BioMerieux Sexually Transmitted Diseases Testing Introduction
    • 11.1.4 BioMerieux Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
    • 11.1.5 BioMerieux Recent Development
  • 11.2 F. Hoffmann La Roche
    • 11.2.1 F. Hoffmann La Roche Company Details
    • 11.2.2 F. Hoffmann La Roche Business Overview
    • 11.2.3 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Introduction
    • 11.2.4 F. Hoffmann La Roche Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
    • 11.2.5 F. Hoffmann La Roche Recent Development
  • 11.3 BD
    • 11.3.1 BD Company Details
    • 11.3.2 BD Business Overview
    • 11.3.3 BD Sexually Transmitted Diseases Testing Introduction
    • 11.3.4 BD Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
    • 11.3.5 BD Recent Development
  • 11.4 Abbott
    • 11.4.1 Abbott Company Details
    • 11.4.2 Abbott Business Overview
    • 11.4.3 Abbott Sexually Transmitted Diseases Testing Introduction
    • 11.4.4 Abbott Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
    • 11.4.5 Abbott Recent Development
  • 11.5 Bio-Rad Laboratories
    • 11.5.1 Bio-Rad Laboratories Company Details
    • 11.5.2 Bio-Rad Laboratories Business Overview
    • 11.5.3 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Introduction
    • 11.5.4 Bio-Rad Laboratories Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
    • 11.5.5 Bio-Rad Laboratories Recent Development
  • 11.6 Abbott
    • 11.6.1 Abbott Company Details
    • 11.6.2 Abbott Business Overview
    • 11.6.3 Abbott Sexually Transmitted Diseases Testing Introduction
    • 11.6.4 Abbott Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
    • 11.6.5 Abbott Recent Development
  • 11.7 Qiagen
    • 11.7.1 Qiagen Company Details
    • 11.7.2 Qiagen Business Overview
    • 11.7.3 Qiagen Sexually Transmitted Diseases Testing Introduction
    • 11.7.4 Qiagen Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
    • 11.7.5 Qiagen Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Sexually Transmitted Diseases Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sexually Transmitted Diseases Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Chlamydia Testing
    Gonorrhea Testing
    Syphilis Testing
    HIV Testing
    HSV Testing
    HPV Testing
    Chancroid Testing
    Other

    Segment by Application
    Clinics
    Hospitals
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    BioMerieux
    F. Hoffmann La Roche
    BD
    Abbott
    Bio-Rad Laboratories
    Abbott
    Qiagen
    Abbott

    Buy now